2nd Annual MHA Opioid Summit: Addressing Perinatal and Neonatal Clinical Care Issues

Contact Our Team


Start Time:12:00 AM
End Time:12:00 AM
Contact Information
Additional Information

This educational activity is jointly provided by AXIS Medical Education and MHA Health Institute.
AxisLogo_4ColorProcess MHA Health Institute Logo

Date & Location

Wednesday, Feb. 27

Courtyard by Marriott
Adams Pointe Conference Center
1500 North East Coronado Dr.
Blue Springs, Mo.

Register on or before Friday, Feb. 15.

Reduced Registrant Fee: $125.00

The majority of conference expenses are covered by Missouri's State Targeted Response to the Opioid Crisis Grant and our sponsors. The reduced registration fee covers portions of the provided meal and other amenities that are not allowed to be covered by the grant.

Funds from the Missouri State Targeted Response for Opioid Crisis Grant, received through the Department of Mental Health and the University of St. Louis, Missouri Institute of Mental Health, have been used for authorized expenses, such as speaker fees, to provide this educational offering at a reduced registration fee.


This Opioid Summit is for providers that need evidence-based guidance for treatment of perinatal women with substance use disorder and the treatment of neonates dependent on controlled substances. Connect and network with community social service providers to improve and sustain coordinated care. Learn from national and state leaders who have data to demonstrate successful interventions.

Thank you to our sponsors!

Platinum Sponsor:
MHI logo

Gold Sponsor:
281 201 & MSMA color logo

Silver Sponsor:
Missouri Academy of Family Physicians


obstetricians, perinatologists, neonatologists, substance use treatment providers, community treatment centers, behavioral health specialists, women’s health nurse practitioners, certified nurse midwives, chief medical officers, chief nursing executives, directors of case management, directors of emergency services, directors of infection control, directors of nursing, pharmacists, directors of outpatient services, directors of patient safety, directors of quality, directors of rehabilitation, directors of social workers and health clinic coordinators

Learning Objectives

Upon completion of this program, participants will be able to:

  • describe current, evidence-based practice of perinatal women who are at-risk or have confirmed substance use disorder
  • describe current, evidence-based practice of neonates with substance use dependencies
  • discuss neonatal abstinence syndrome
  • describe current, evidence-based information about managing pain in childbearing-age women
  • describe current, evidence-based strategies of integrating localized recovery-oriented systems of care


7:30 a.m. — Registration/Continental Breakfast

8:30 a.m. — Welcome and Opening Remarks
Leslie L. Porth, Ph.D., MPH, R.N.
Senior Vice President of Strategic Quality Initiatives
Missouri Hospital Association
Jefferson City

Rachel P. Winograd, Ph.D.
Assistant Research Professor
Missouri Institute of Mental Health
St. Louis

Tim Rudder, LMSW
State Opioid Coordinator
Missouri Department of Mental Health
Division of Behavioral Health
Jefferson City

8:45 a.m. — Caring for the Mother and Child: Dyad Treatment for Opioid and Other Substance Use Disorders
Hendree' Jones, Ph.D.

Professor, Department of Obstetrics and Gynecology
University of North Carolina Horizons Program
Chapel Hill

Historical and current context of opioid use disorders among women in the U.S. will be discussed. The presentation also will summarize the current research and guidance available to help improve outcomes among women with opioid and other substance use disorders during the perinatal period. Approaches to improve parenting and child outcomes will be highlighted.

10 a.m. — Break

10:15 a.m. — Missouri Practice Panel — Current Best Practice
Facilitator: Alison R. Williams, MBA-HCM, BSN, R.N.
Vice President of Clinical Quality Improvement
Missouri Hospital Association
Jefferson City

Jaye M Shyken, M.D.
Associate Professor
Department of Obstetrics, Gynecology and Women's Health
Division of Maternal-Fetal Medicine
St. Louis University School of Medicine
Medical Director, WISH (Women and Infant Substance Help)

Elizabeth Simpson, M.D.
Director, Well Newborn Care, Division of Neonatology
Children’s Mercy Kansas City
Truman Medical Center
Kansas City, Mo.

Louise Thurlow, MSN, APRN
Neonatal Nurse Practitioner
Mednax Medical Group
Saint Luke's Health System
Kansas City, Mo.

Daniel Jackson, M.D., M.S., FACOG
Maternal and Fetal Medicine, OB/GYN,
Assistant Professor of Clinical OB/GYN
University of Missouri Health Care
Columbia, Mo.

Missouri hospitals and providers are working to provide innovative, comprehensive care to women with substance use disorders and their newborns who are subsequently substance-exposed and affected. This care requires early screening, intervention and ongoing follow-up to support the mother-baby dyad. During this panel presentation, a brief overview of the key care issues will be discussed, followed by four panelists who will each present how they have improved care for maternal and newborn patients.

11:30 a.m. — Lunch (provided)

12:30 p.m. — Trauma and Recovery
Tonier Cain-Muldrow
Chief Executive Officer
Neen Cares Inc.

Tonier “Neen” Cain-Muldrow will take you on a journey to places and subjects that most find too difficult or uncomfortable to fathom. But it is Neen’s joyous spirt and astonishing inner strength that leaps directly into your hearts, inspiring renewed hope and compassion for those still living on the fringes. For two decades, Neen hustled on the streets of Annapolis, Md., desperately feeding an insatiable crack addiction and racking up 83 arrests along the way. Rapes and beatings were a routine part of life; home was underneath a bridge or inside the locked cage of a prison. In 2004, pregnant and incarcerated for violation of parole, she was provided the opportunity to go to a community trauma, mental health and addictions program.

Today, she is the founder and CEO of Healing Neen Inc., and she works for the National Center for Trauma-Informed Care, dedicating her life to being a voice for those still lost and still silent. Traveling the world to give speeches and work one-on-one with women in prisons and hospitals, Neen continues to transform her own life while helping others embrace her motto, “Where there’s breath, there’s hope.”

1:30 p.m. — Break

1:45 p.m. — Community Service Panel
Facilitator: Shawn W. Billings
Director of Substance Use Programming
Missouri Hospital Association
Jefferson City

Sharon Spruell, M.A., B.A.
Chief Executive Officer
Queen of Peace Center
St. Louis

Kael Maness
Recovery Coach
Preferred Family Healthcare
St. Louis

David Stoecker, MSW
Advocacy and Education Outreach Coordinator
Missouri Recovery Network
St. Louis

Bobbi Jo Reed
Healing House Inc.
Kansas City, Mo.

Decreasing the prevalence of neonatal abstinence syndrome requires a comprehensive community response. Mothers and newborns continue to be affected by delays in seeking appropriate care due to stigma, access to care due to socioeconomic factors and receiving evidence-based treatments when care is accessible. This panel will discuss the challenges of providing maternal, newborn and child health services and share in some of the successes achieved through community empowerment, participation and ownership of locally-based interventions, aligned with best practice.

3 p.m. — Opioids and the 4th Trimester: Family-Centered Care
Mishka Terplan, M.D. MPH, FACOG, DFASAM
Professor, Departments Obstetrics and Gynecology and Psychiatry
Virginia Commonwealth University

The postpartum period is a time of increased vulnerabilities, especially for women with opioid use disorder. Dr. Terplan will review the care considerations in this 4th trimester, emphasizing the importance of holistic and family-centered care.

4:15 p.m. — Closing Remarks
Leslie L. Porth, Ph.D., MPH, R.N.

4:30 p.m. — Adjournment


Hendree' Jones is an internationally recognized expert in the development and examination of both behavioral and pharmacologic treatments for pregnant women and their children in risky life situations. She has received continuous National Institutes of Health funding since 1994 and has written more than 195 peer-reviewed publications. Dr. Jones also has authored two books – one on treating patients for substance use disorders and the other on comprehensive care for women who are pregnant and have substance use disorders.

Jaye Shyken is a maternal-fetal medicine specialist in the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology and Women’s Health at St. Louis University School of Medicine. Her clinical activities are primarily at St. Marys’ Hospital.

She has a long-time interest in substance use disorders in pregnancy. In 2014, SSM launched a Women and Infants Substance Help, and Dr. Shyken serves as the founding medical director.

Dr. Shyken serves on several task forces related to substance use recovery for pregnant women, including serving as the co-clinical lead at the state level for the Illinois Perinatal Quality Collaborative, Maternal and Neonatal Opioid initiate. She lectures frequently on topics related to narcotic addiction in pregnancy, and she has a special interest in yoga for 12-step recovery.

Elizabeth Simpson is a pediatrician in Kansas City, Mo., and is affiliated with Children's Mercy Kansas City. She received her medical degree from University of Missouri - Kansas City School of Medicine and has been in practice for more than 20 years.

Daniel Jackson is board certified in maternal-fetal medicine and obstetrics and gynecology. He completed his residency at the University of Missouri and his fellowship at the University of Oklahoma. Dr. Jackson became interested in treatment of substance use in pregnancy and obtained training in the use of buprenorphine in pregnancy.

Louise Thurlow has been a nurse practitioner for 30 years with a special interest in neonatal abstinence syndrome for the last 20 years. She has been involved in developing a standardized approach for the infant exposed to opiates during pregnancy. Mednax Medical Group has recently implemented the “Eat, Sleep and Console” assessment for neonatal abstinence.

Tonier “Neen” Cain-Muldrow is a former team leader for the National Center for Trauma-Informed Care with the National Association of State Mental Health Program Directors. Cain-Muldrow is a consumer advocate who speaks all over the world on trauma, incarceration and recovery. She is the CEO and founder of Healing Neen Inc. She was featured in the documentary “Behind Closed Doors: Trauma Survivors and the Psychiatric System.” Cain-Muldrow is the co-producer of the award-winning film “Healing Neen” and the executive producer of “Walking Thru Bullets.” She is the founder and Co-CEO of MET-R, a global nonprofit that provides services for trauma survivors worldwide.

Sharon Spruell is the CEO at Queen of Peach Center, a family-centered treatment provider of women with substance use disorders, co-occurring disorders and trauma in the St. Louis area. She began working with Queen of Peach Center in 2017 as the clinical director and moved into the role of CEO in 2018. Spruell has a master’s degree in counseling from Webster University and a bachelor's degree in psychology from Saint Louis University.

Kael Maness is a recovery coach for Engaging Patients In Care Coordination outreach. He is in long-term recovery from a substance use disorder. His aim is to strengthen communities decimated by addiction using medication-assisted treatment as part of a holistic approach. Maness earned his drug counseling certification.

David Stoecker is the advocacy and education outreach coordinator for the Missouri Recovery Network and a consultant on several federal grants. He was the 2017 Missouri Mental Health Champion for recovery, a 2018 SAMHSA Voice Award winner and sits on several boards. He is the director of the nonprofit organization Better Life in Recovery and co-founder of the Springfield Recovery Community Center. Stoecker has been featured in Christianity Today, Guidepost Magazine and was shown on the 700 Club this year.

Bobbi Jo Reed is in long-term recovery with 23 years of continuous sobriety. She has been involved in recovery housing for 17 years and currently houses 180 adults and 30 children. Reed is the Founder/CEO of Healing House Inc. and the Recovery Community Center, which currently is the state targeted response for the opiate epidemic in Kansas City. She is the Recovery Mental Health Champion of 2018.

Mishka Terplan is board certified in both obstetrics and gynecology and addiction medicine. His clinical, research and advocacy issues lie along the intersection of reproductive and behavioral health. Dr. Terplan is a professor in OB/GYN and psychiatry at Virginia Commonwealth University and medical director at MOTIVATE, an outpatient addiction treatment clinic that provides special services for postpartum women.

Continuing Education

Participants must attend the program in its entirety to receive a certificate of completion and continuing education contact hours.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MHA Health Institute and AXIS Medical Education. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation for Physicians
AXIS Medical Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation for Pharmacists
This knowledge based activity is approved for 6.0 contact hours of continuing pharmacy education credit JA4008106-9999-19-005-L01-P.

Credit Designation for Nursing
AXIS Medical Education designates this continuing nursing education activity for 6.0 contact hours.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Quality Professionals
This program has been approved by the National Association for Healthcare Quality for 6.0 CPHQ continuing education credits.

Social Workers
This program is Approved by the National Association of Social Workers (Approval # 886749394-7981) for 6 continuing education contact hours.

Requirements for Credit:

  • Attend/participate in the educational activity and review all course materials.
  • Complete the CE Declaration form online by 11:59 p.m. ET Friday, March 16, 2018. Instructions will be provided. If you do not enter the online portal by the above date, you will not be able to retrieve your statement of participation.
  • Upon successful completion of the online form, your statement of completion will be presented to you to print. Pharmacists: Your record will be automatically uploaded to CPE Monitor.

AXIS Contact Information
For information about the accreditation of this program please contact AXIS atinfo@axismeded.org.

Disclosure of Conflicts of Interest
AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

 Name of Faculty or Presenter  Reported Financial Relationship
 Hendree' Jones, Ph.D.
 Nothing to disclose
 Jaye M Shyken, M.D.  Nothing to disclose
 Elizabeth Simpson, M.D.
 Nothing to disclose
 Louise Thurlow, MSN, APRN  Nothing to disclose
 Daniel Jackson, M.D.
 Nothing to disclose
 Tonier Cain  Nothing to disclose
 Sharon Spruell, M.A., B.A.
 Nothing to disclose
 Kael Maness  Nothing to disclose
 David Stoecker, MSW  Nothing to disclose
 Bobbi Jo Reed  Nothing to disclose
 Mishka Terplan, M.D. MPH, FACOG, DFASAM  Nothing to disclose

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

 Name of Planner/Manager  Reported Financial Relationship
 Rita F. Kay  Nothing to disclose
 Holly M. Hampe, D.Sc., R.N., MHA, MRM  Nothing to disclose
 Dee Morgillo, M.Ed., CHCP  Nothing to disclose
 Robert Mocharnuk. MD  Common Stock: Merck

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Americans With Disabilities Act
In compliance with the Americans With Disabilities Act, we will make every reasonable effort to accommodate your request. For any special requests, please contact MHA Health Institute at 573/893-3700 before the meeting dates.